Steven A. Rosenberg
#187,851
Most Influential Person Now
Steven A. Rosenberg's AcademicInfluence.com Rankings
Steven A. Rosenbergphilosophy Degrees
Philosophy
#12305
World Rank
#17073
Historical Rank
Logic
#9153
World Rank
#11559
Historical Rank
Steven A. Rosenbergbiology Degrees
Biology
#15819
World Rank
#19884
Historical Rank
Cell Biology
#886
World Rank
#909
Historical Rank
Molecular Biology
#2768
World Rank
#2811
Historical Rank
Biochemistry
#2786
World Rank
#2976
Historical Rank
Download Badge
Philosophy Biology
Steven A. Rosenberg's Degrees
- PhD Biochemistry Stanford University
- Doctorate Medicine Stanford University
Why Is Steven A. Rosenberg Influential?
(Suggest an Edit or Addition)Steven A. Rosenberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Regulation of Integrin Function by the Urokinase Receptor (1996) (785)
- Peptoids: a modular approach to drug discovery. (1992) (763)
- Identification of the urokinase receptor as an adhesion receptor for vitronectin. (1994) (631)
- Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? (1996) (471)
- Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. (1996) (270)
- Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration* (1996) (243)
- Recent advances in the molecular biology of hepatitis C virus. (2001) (213)
- Glucose oxidase from Aspergillus niger. Cloning, gene sequence, secretion from Saccharomyces cerevisiae and kinetic analysis of a yeast-derived enzyme. (1990) (208)
- Identification of a Urokinase Receptor-Integrin Interaction Site (2000) (204)
- High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. (1994) (193)
- Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsin (1984) (168)
- Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein. (1990) (145)
- Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg white lysozyme. (1989) (142)
- Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice (1998) (141)
- Substrate Specificity of the Escherichia coli Outer Membrane Protease OmpT (2004) (104)
- Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. (1985) (101)
- Nonproteolytic role for the urokinase receptor in cellular migration in vivo. (2000) (95)
- Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity (2001) (94)
- Amino Terminal Acetylation of Authentic Human Cu,Zn Superoxide Dismutase Produced in Yeast (1987) (93)
- Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. (1996) (84)
- The functional domains of coagulation factor VIII:C. (1986) (80)
- Semirational design of a potent, artificial agonist of fibroblast growth factor receptors (1999) (65)
- Expression and characterization of recombinant hepatitis A virus 3C proteinase. (1992) (58)
- Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth (1999) (49)
- Fermentation of a Yeast Producing A. Niger Glucose Oxidase: Scale-Up, Purification and Characterization of the Recombinant Enzyme (1991) (42)
- Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein (2000) (29)
- Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism (2004) (28)
- Reconstruction and testing of ancestral proteins. (1993) (27)
- Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain. (1995) (21)
- New developments in the urokinase-type plasminogen activator system (2001) (20)
- Stability effects associated with the introduction of a partial and a complete Ca(2+)-binding site into human lysozyme. (1993) (16)
- THE FUNCTIONAL DOMAINS OF COAGULATION FACTOR VIII (1987) (10)
- A New Production Method for Glucose-oxidase (1992) (10)
- Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality. (1998) (8)
- Diverse Approaches to Combinatorial Library Design (1998) (8)
- Characterization of antithrombins produced by active site mutagenesis of human alpha 1-antitrypsin expressed in yeast. (1989) (8)
- Chapter 12. The Urokinase-type Plasminogen Activator and Its Receptor in Cancer (1999) (7)
- Chapter 5. Trophic Factors and their Receptors in the CNS (1992) (7)
- Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein. (2000) (6)
- Random Peptide Bacteriophage Display as a Probe for Urokinase Receptor Ligands (2002) (5)
- Modulators of the urokinase-type plasminogen activation system for cancer (2000) (4)
- Synthesis and Assembly of Hepatitis B Virus Antigens in Heterologous Systems (1984) (4)
- Galactose-regulated expression of hepatitis B surface antigen by a recombinant yeast (1989) (3)
- 181 Identification and characterization of small molecule peptidic and non-peptidic urokinase receptor antagonists (1997) (1)
- 168 Structure function studies on the urokinase receptor: Urokinase system. Murine-human hybrid proteins define critical regions for species specificity (1997) (1)
- 78 Receptor-independent role of urokinase-type plasminogen activator during vascular wound healing in mice (1997) (1)
- Elevated Hefetranskription using a hybrid construction of the promoter region. (1985) (0)
- Vector for expression of a DNA segment in yeast (1983) (0)
- Protease inhibitors of the alpha-1-antitrypsin type modified aktiever point and their preparation. (1985) (0)
- Vector for expression in yeast, comprising a foreign DNA coding segment and a method for expression of the DNA coding segment in yeast by means of such a vector (1983) (0)
- 9 The Utilization of Platelets and Whole Cells for the Selection of Peptides Ligands from Phage Display Libraries (1996) (0)
- Glucose Oxidase , Cloning and Expression 3795 (2001) (0)
- Expression systems for yeast PyK promoter containing vectors and synthesis of foreign proteins. (1984) (0)
- STUDIES ON YEAST-DERIVED AND MUTANT GLUCOSE OXIDASES (1991) (0)
- Expression of yeast expression vector (1992) (0)
- Expression systems for yeast vectors containing a GAPDH promoter and surface antigen synthesis of Hepatitis B (1984) (0)
- Methods for the preparation of enzymatically active lysozyme, synthetic gene for human lysozyme, and yeast cells, which are capable of expressing the synthetic gene (1989) (0)
- Abstract LB-40: Inhibition of anchorage-independent growth of melanoma cell lines using Riluzole in combination with PI3 kinase pathway inhibitors (2010) (0)
- Expression systems for yeast with a GAPDH promoter containing vectors and synthesis of foreign proteins. (1984) (0)
- 85 Inhibition of in vivo tumor growth by murine and human urokinase receptor antagonists (1997) (0)
- Yeast as an organism for the industrial production of medium value enzymes: a case study, glucose oxidase. (1990) (0)
- Peptoids : A modular approach to drug discovery ( chemical diversity / peptide libraries / N-alkylglycine / N-substituted glycine ) (2004) (0)
This paper list is powered by the following services:
